Citations (55)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Yuhan Qin, Yong Qiao, Dong Wang, Gaoliang Yan, Chengchun Tang & Genshan Ma. (2021) The Predictive Value of Soluble Urokinase-Type Plasminogen Activator Receptor in Contrast-Induced Acute Kidney Injury in Patients Undergoing Percutaneous Coronary Intervention. International Journal of General Medicine 14, pages 6497-6504.
Read now
Read now
Dimitrios Velissaris, Charalampos Pierrakos, Vasileios Karamouzos, Nikolas Dimitrios Pantzaris & Charalampos Gogos. (2021) The use of soluble urokinase plasminogen activator receptor (suPAR) as a marker of sepsis in the emergency department setting. A current review. Acta Clinica Belgica 76:1, pages 79-84.
Read now
Read now
Thor A. Skovsted, Eva Rabing Brix Petersen, Maj-Britt Fruekilde, Andreas Kristian Pedersen, Tomasz Pielak & Jesper Eugen-Olsen. (2020) Validation of suPAR turbidimetric assay on Cobas® (c502 and c702) and comparison to suPAR ELISA. Scandinavian Journal of Clinical and Laboratory Investigation 80:4, pages 327-335.
Read now
Read now
Articles from other publishers (52)
Alexander C. Reisinger, Stefan Hatzl, Juergen Prattes, Gerald Hackl, Gernot Schilcher, Florian Eisner, Tobias Niedrist, Reinhard Raggam, Robert Krause & Philipp Eller. (2023) Soluble urokinase plasminogen activator receptor (suPAR) in bronchoalveolar fluid and blood in critically ill patients—a prospective cohort study. Infection.
Crossref
Crossref
Nessn Azawi, Karina Sif Sondergaard Mosholt, Nathalie Demuth Fryd, Lars Lund, Juan Ignacio Brignone, Nanna Hvid, Helle Wulf-Johansson, Ole Birger Vesterager Pedersen, Susanne Gjørup Saekmose & Saeed Dabestani. (2023) suPARnostic: an advanced predictive tool for detecting recurrence in renal cell carcinoma. BMC Urology 23:1.
Crossref
Crossref
Mariangela Manfredi, Lieve Van Hoovels, Maurizio Benucci, Riccardo De Luca, Carmela Coccia, Pamela Bernardini, Edda Russo, Amedeo Amedei, Serena Guiducci, Valentina Grossi, Xavier Bossuyt, Carlo Perricone & Maria Infantino. (2023) Soluble Urokinase Plasminogen Activator Receptor (suPAR) in Autoimmune Rheumatic and Non Rheumatic Diseases. Journal of Personalized Medicine 13:4, pages 688.
Crossref
Crossref
S. L. Morozov & V. V. Dlin. (2023) The problem of focal-segmental glomerulosclerosis in primary glomerulonephritis. Nephrology (Saint-Petersburg) 27:1, pages 108-114.
Crossref
Crossref
Shunming Zhang, Huiping Li, Gunnar Engström, Kaijun Niu, Lu Qi, Yan Borné & Emily Sonestedt. (2023) Milk intake, lactase persistence genotype, plasma proteins and risks of cardiovascular events in the Swedish general population. European Journal of Epidemiology 38:2, pages 211-224.
Crossref
Crossref
Sang Ho Shin & Yong-Ku Kim. 2023. Neuroinflammation, Gut-Brain Axis and Immunity in Neuropsychiatric Disorders. Neuroinflammation, Gut-Brain Axis and Immunity in Neuropsychiatric Disorders
105
134
.
Toshiya Mitsunaga, Yuhei Ohtaki, Yutaka Seki, Kunihiro Mashiko, Masahiko Uzura, Kenji Okuno & Satoshi Takeda. (2023)
The predictive value of modified soluble urokinase plasminogen activator receptor (
suPAR
) with National Early Warning Score (
NEWS
) for mortality in emergency elderly patients in Japan: a prospective pilot study
. Acute Medicine & Surgery 10:1.
Crossref
Crossref
Toshiya Mitsunaga, Yuhei Ohtaki, Wataru Yajima, Kei Sugiura, Yutaka Seki, Kunihiro Mashiko, Masahiko Uzura & Satoshi Takeda. (2022) Ability of combined soluble urokinase plasminogen activator receptor to predict preventable emergency attendance in older patients in Japan: a prospective pilot study. PeerJ 10, pages e14322.
Crossref
Crossref
Liang Wang, Xite Lin & Pengming Sun. (2022) uPAR, beyond regulating physiological functions, has orchestrated roles in cancer (Review). International Journal of Oncology 61:6.
Crossref
Crossref
Alexandre Quéneau, Marc-Antoine Pistorius, Jérôme Connault, Alizée Raimbeau, Giovanni Gautier, Guillaume Bergère, Mathieu Artifoni, Cécile Durant, Antoine Bénichou, Jeanne Hersant & Olivier Espitia. (2022) Case–Control Study on Exercise-Induced Vasculitis in Hikers. Angiology 73:7, pages 643-648.
Crossref
Crossref
Sergio M. De Almeida, Indianara Rotta, Bin Tang, Anya Umlauf, Florin Vaida, Mariana Cherner, Donald Franklin, Scott Letendre & Ronald J. Ellis. (2022) Higher Cerebrospinal Fluid Soluble Urokinase-type Plasminogen Activator Receptor, But Not Interferon γ-inducible Protein 10, Correlate With Higher Working Memory Deficits. JAIDS Journal of Acquired Immune Deficiency Syndromes 90:1, pages 106-114.
Crossref
Crossref
Shujuan Yu, Yaqun Sui, Jiawei Wang, Yongdong Li, Hanlin Li, Yingping Cao, Liqing Chen, Longguang Jiang, Cai Yuan & Mingdong Huang. (2022) Crystal structure and cellular functions of uPAR dimer. Nature Communications 13:1.
Crossref
Crossref
Line Jee Hartmann Rasmussen, Jens Emil Vang Petersen & Jesper Eugen-Olsen. (2021) Soluble Urokinase Plasminogen Activator Receptor (suPAR) as a Biomarker of Systemic Chronic Inflammation. Frontiers in Immunology 12.
Crossref
Crossref
Sebastian Roed Rasmussen, Rikke Vibeke Nielsen, Rasmus Møgelvang, Sisse Rye Ostrowski & Hanne Berg Ravn. (2021) Prognostic value of suPAR and hsCRP on acute kidney injury after cardiac surgery. BMC Nephrology 22:1.
Crossref
Crossref
Björn Fagerberg & Lars Barregard. (2021) Review of cadmium exposure and smoking‐independent effects on atherosclerotic cardiovascular disease in the general population. Journal of Internal Medicine 290:6, pages 1153-1179.
Crossref
Crossref
Antonella Trotta, Louise Arseneault, Andrea Danese, Valeria Mondelli, Line J.H. Rasmussen & Helen L. Fisher. (2021) Associations between childhood victimization, inflammatory biomarkers and psychotic phenomena in adolescence: A longitudinal cohort study. Brain, Behavior, and Immunity 98, pages 74-85.
Crossref
Crossref
David A. Skerrett‐Byrne, Elizabeth G. Bromfield, Heather C. Murray, M. Fairuz B. Jamaluddin, Andrew G. Jarnicki, Michael Fricker, Ama T. Essilfie, Bernadette Jones, Tatt J. Haw, Daniel Hampsey, Amanda L. Anderson, Brett Nixon, Rodney J. Scott, Peter A. B. Wark, Matthew D. Dun & Philip M. Hansbro. (2021) Time‐resolved proteomic profiling of cigarette smoke‐induced experimental chronic obstructive pulmonary disease. Respirology 26:10, pages 960-973.
Crossref
Crossref
Rafael Fernandez-Botran, Yvette Z. Szabo, Keith B. Lyle & Tamara L. Newton. (2021) The levels of soluble urokinase plasminogen activator receptor (suPAR) in saliva are influenced by acute stress. Biological Psychology 165, pages 108147.
Crossref
Crossref
Kyle J. Bourassa, Line J.H. Rasmussen, Andrea Danese, Jesper Eugen-Olsen, HonaLee Harrington, Renate Houts, Richie Poulton, Sandhya Ramrakha, Karen Sugden, Ben Williams, Terrie E. Moffitt & Avshalom Caspi. (2021) Linking stressful life events and chronic inflammation using suPAR (soluble urokinase plasminogen activator receptor). Brain, Behavior, and Immunity 97, pages 79-88.
Crossref
Crossref
Alexander C. Reisinger, Tobias Niedrist, Florian Posch, Stefan Hatzl, Gerald Hackl, Juergen Prattes, Gernot Schilcher, Anna-Maria Meißl, Reinhard B. Raggam, Markus Herrmann & Philipp Eller. (2021) Soluble urokinase plasminogen activator receptor (suPAR) predicts critical illness and kidney failure in patients admitted to the intensive care unit. Scientific Reports 11:1.
Crossref
Crossref
Marius Ahm Stauning, Izzet Altintas, Thomas Kallemose, Jesper Eugen-Olsen, Mette Bendtz Lindstrøm, Line Jee Hartmann Rasmussen, Hejdi Gamst-Jensen, Jan O. Nehlin, Ove Andersen & Jens Tingleff. (2021) Soluble Urokinase Plasminogen Activator Receptor as a Decision Marker for Early Discharge of Patients with COVID-19 Symptoms in the Emergency Department. The Journal of Emergency Medicine 61:3, pages 298-313.
Crossref
Crossref
Sebastian Roed Rasmussen, Rikke Vibeke Nielsen, Frank Eriksson, Maria Dons, Anne Grønborg Vedel, Katrine Bredahl Buggeskov, Rasmus Møgelvang, Sisse Rye Ostrowski & Hanne Berg Ravn. (2021) Prognostic Value of Soluble Urokinase-Type Plasminogen Activator Receptor and High-Sensitivity C-Reactive Protein on Postoperative Mortality in Patients Undergoing Elective On-Pump Cardiac Surgery. Journal of Cardiothoracic and Vascular Anesthesia 35:8, pages 2415-2423.
Crossref
Crossref
Joseph Dowsett, Egil Ferkingstad, Line Jee Hartmann Rasmussen, Lise Wegner Thørner, Magnús K. Magnússon, Karen Sugden, Gudmar Thorleifsson, Mike Frigge, Kristoffer Sølvsten Burgdorf, Sisse Rye Ostrowski, Erik Sørensen, Christian Erikstrup, Ole Birger Pedersen, Thomas Folkmann Hansen, Karina Banasik, Søren Brunak, Steffen Andersen, Gregor Jemec, Poul Jennum, Rene Kasper Nielsen, Mette Nyegaard, Helene Martina Paarup, Mikkel Petersen, Thomas Werge, Daniel Gudbjartsson, Kari Stefansson, Unnur Þorsteinsdóttir, Vinicius Tragante, Sigrun Helga Lund, Lilja Stefansdottir, Bjarni Gunnarson, Richie Poulton, Louise Arseneault, Avshalom Caspi, Terrie E. Moffitt, Daníel Gudbjartsson, Jesper Eugen-Olsen, Hreinn Stefánsson, Kári Stefánsson & Henrik Ullum. (2021) Eleven genomic loci affect plasma levels of chronic inflammation marker soluble urokinase-type plasminogen activator receptor. Communications Biology 4:1.
Crossref
Crossref
Abderrahim Oulhaj, Ahmed R. Alsuwaidi, Abubaker Suliman, Huda Gasmelseed, Shaima Khan, Shamma Alawi, Yaman Hukan, Junu George, Fayez Alshamsi, Farrukh Sheikh, Zahir Osman Eltahir Babiker, Juergen Prattes & Harald Sourij. (2021) Admission levels of Soluble Urokinase Plasminogen Activator Receptor (suPAR) are Associated with the Development of Severe Complications in Hospitalised COVID-19 Patients: A Prospective Cohort Study. International Journal of Infectious Diseases 107, pages 188-194.
Crossref
Crossref
Peter Durand Skottrup, Thomas Kallemose, Diana Espino, Rocio Infante‐Ramirez, Soren Brage, Dijana Terzic, Jens Peter Goetze, Jesper Kjaergaard & Dirk Lund Christensen. (2020) Plasma marker for systemic inflammation is increased in Mexican Tarahumara following ultra‐distance running. American Journal of Human Biology 33:3.
Crossref
Crossref
Cai Yuan, Zhanzhi Guo, Shujuan Yu, Longguang Jiang & Mingdong Huang. (2021) Development of inhibitors for uPAR: blocking the interaction of uPAR with its partners. Drug Discovery Today 26:4, pages 1076-1085.
Crossref
Crossref
Laura Hewitson, Jeremy A. Mathews, Morgan Devlin, Claire Schutte, Jeon Lee & Dwight C. German. (2021) Blood biomarker discovery for autism spectrum disorder: A proteomic analysis. PLOS ONE 16:2, pages e0246581.
Crossref
Crossref
Qiuyun Guo, Jordan R. Yaron, John W. WallenIIIIII, Kyle F. Browder, Ryan Boyd, Tien L. Olson, Michelle Burgin, Peaches Ulrich, Emily Aliskevich, Lauren N. Schutz, Petra Fromme, Liqiang Zhang & Alexandra R. Lucas. (2021) PEGylated Serp-1 Markedly Reduces Pristane-Induced Experimental Diffuse Alveolar Hemorrhage, Altering uPAR Distribution, and Macrophage Invasion. Frontiers in Cardiovascular Medicine 8.
Crossref
Crossref
Conxita Jacobs-Cachá, Ander Vergara, Clara García-Carro, Irene Agraz, Nestor Toapanta-Gaibor, Gema Ariceta, Francesc Moreso, Daniel Serón, Joan López-Hellín & Maria José Soler. (2021) Challenges in primary focal segmental glomerulosclerosis diagnosis: from the diagnostic algorithm to novel biomarkers. Clinical Kidney Journal 14:2, pages 482-491.
Crossref
Crossref
Marcin Kozakiewicz, Magdalena Trzcińska-Kubik & Rafał Nikodem Wlazeł. (2021) Index of Body Inflammation for Maxillofacial Surgery Purpose-to Make the Soluble Urokinase-Type Plasminogen Activator Receptor Serum Level Independent on Patient Age. Applied Sciences 11:3, pages 1345.
Crossref
Crossref
Line Jee Hartmann Rasmussen, Avshalom Caspi, Antony Ambler, Andrea Danese, Maxwell Elliott, Jesper Eugen-Olsen, Ahmad R Hariri, HonaLee Harrington, Renate Houts, Richie Poulton, Sandhya Ramrakha, Karen Sugden, Benjamin Williams & Terrie E Moffitt. (2021) Association Between Elevated suPAR, a New Biomarker of Inflammation, and Accelerated Aging. The Journals of Gerontology: Series A 76:2, pages 318-327.
Crossref
Crossref
Christine Borgen Linander, Thomas Kallemose, Lillian Moerch Joergensen, Ove Andersen, Jan O. Nehlin & Baker Nawfal Jawad. (2020) The effect of circadian-adjusted LED-based lighting on sleep, daytime sleepiness and biomarkers of inflammation in a randomized controlled cross-over trial by pragmatic design in elderly care home dwellers. Archives of Gerontology and Geriatrics 91, pages 104223.
Crossref
Crossref
Fernando M. Delgado-Chaves, Francisco Gómez-Vela, Federico Divina, Miguel García-Torres & Domingo S. Rodriguez-Baena. (2020) Computational Analysis of the Global Effects of Ly6E in the Immune Response to Coronavirus Infection Using Gene Networks. Genes 11:7, pages 831.
Crossref
Crossref
Lamiaa Hamie, Edward Eid, Ossama Abbas, Remi Safi, Tarak Nammour, Hani Tamim, Maha Makki, Carla Stephan, Divina Hasbani, Hisham Wehbe, Nohra Ghaoui, Mariana Hawa, Nourhan Nasser, Assaad Eid, Abdul‐Ghani Kibbi & Mazen Kurban. (2020) SuPAR, a potential inflammatory mediator in psoriasis pathogenesis. Clinical and Experimental Pharmacology and Physiology.
Crossref
Crossref
Jens Emil Vang Petersen, Thomas Kallemose, Karen D Barton, Avshalom Caspi & Line Jee Hartmann Rasmussen. (2020) Soluble urokinase plasminogen activator receptor (suPAR) as a prognostic marker of mortality in healthy, general and patient populations: protocol for a systematic review and meta-analysis. BMJ Open 10:7, pages e036125.
Crossref
Crossref
Line Jee Hartmann Rasmussen, Terrie E. Moffitt & Avshalom Caspi. (2020) Major Concerns Over Improving Measurement of Inflammation Remain—Reply. JAMA Pediatrics 174:6, pages 624.
Crossref
Crossref
Jesper Friis Petersen, Anna García-Alix Grynnerup, Nikki Have Mitchell, Kristine Løssl, Steen Sørensen, Anette Lindhard, Lennart Friis-Hansen, Anja Pinborg, Anders Nyboe Andersen & Ellen Løkkegaard. (2020) Soluble urokinase plasminogen activator receptor (suPAR) as a biomarker of early pregnancy location and viability compared with hCG, progesterone and estradiol. Journal of Reproductive Immunology 138, pages 103103.
Crossref
Crossref
James P. Higham, Christiane Stahl-Hennig & Michael Heistermann. (2020) Urinary suPAR: a non-invasive biomarker of infection and tissue inflammation for use in studies of large free-ranging mammals. Royal Society Open Science 7:2, pages 191825.
Crossref
Crossref
Jan O. Nehlin & Ove Andersen. 2020. Explaining Health Across the Sciences. Explaining Health Across the Sciences
243
270
.
Hillarey Stone, Bliss Magella & Michael R. Bennett. (2019) The Search for Biomarkers to Aid in Diagnosis, Differentiation, and Prognosis of Childhood Idiopathic Nephrotic Syndrome. Frontiers in Pediatrics 7.
Crossref
Crossref
Emilie Garnæs, Christian Mortensen, Lise Hobolth, Ove Andersen, Jan Nehlin & Søren Møller. (2019) Kinetics of the soluble urokinase plasminogen activator receptor (suPAR) in cirrhosis. PLOS ONE 14:8, pages e0220697.
Crossref
Crossref
Maurizio Cammalleri, Massimo Dal Monte, Vincenzo Pavone, Mario De Rosa, Dario Rusciano & Paola Bagnoli. (2019) The uPAR System as a Potential Therapeutic Target in the Diseased Eye. Cells 8:8, pages 925.
Crossref
Crossref
Janice Chew-Harris, Sarah Appleby, A. Mark Richards, Richard W. Troughton & Christopher J. Pemberton. (2019) Analytical, biochemical and clearance considerations of soluble urokinase plasminogen activator receptor (suPAR) in healthy individuals. Clinical Biochemistry 69, pages 36-44.
Crossref
Crossref
Min Liu, Lin Lin, Gunilla Høyer‐Hansen, Michael Ploug, Hanlin Li, Longguang Jiang, Cai Yuan, Jinyu Li & Mingdong Huang. (2019)
Crystal structure of the unoccupied murine urokinase‐type plasminogen activator receptor (
uPAR
) reveals a tightly packed DII–DIII unit
. FEBS Letters.
Crossref
Crossref
Fabrizio Scotti, Paolo Milani, Marco Setaccioli, Silvia Maestroni, Nicolai Sidenius, Valentina De Lorenzi, Amedeo Massacesi, Fulvio Bergamini & Gianpaolo Zerbini. (2019) Increased soluble urokinase plasminogen activator receptor (suPAR) levels in neovascular age-related macular degeneration: a role for inflammation in the pathogenesis of the disease?. Graefe's Archive for Clinical and Experimental Ophthalmology 257:5, pages 899-903.
Crossref
Crossref
Line Jee Hartmann Rasmussen, Terrie E. Moffitt, Jesper Eugen-Olsen, Daniel W. Belsky, Andrea Danese, HonaLee Harrington, Renate M. Houts, Richie Poulton, Karen Sugden, Benjamin Williams & Avshalom Caspi. (2019) Cumulative childhood risk is associated with a new measure of chronic inflammation in adulthood. Journal of Child Psychology and Psychiatry 60:2, pages 199-208.
Crossref
Crossref
Martin Schultz, Line Jee Hartmann Rasmussen, Malene H. Andersen, Jakob S. Stefansson, Alexander C. Falkentoft, Morten Alstrup, Andreas Sandø, Sarah L. K. Holle, Jeppe Meyer, Peter B. S. Törnkvist, Thomas Høi-Hansen, Erik Kjøller, Birgitte Nybo Jensen, Morten Lind, Lisbet Ravn, Thomas Kallemose, Theis Lange, Lars Køber, Lars Simon Rasmussen, Jesper Eugen-Olsen & Kasper Karmark Iversen. (2018) Use of the prognostic biomarker suPAR in the emergency department improves risk stratification but has no effect on mortality: a cluster-randomized clinical trial (TRIAGE III). Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine 26:1.
Crossref
Crossref
Jeppe Meyer, Morten Alstrup, Line J. H. Rasmussen, Martin Schultz, Steen Ladelund, Thomas H. Haupt, Jens Tingleff, Kasper Iversen & Jesper Eugen-Olsen. (2018) suPAR is associated with risk of future acute surgery and post-operative mortality in acutely admitted medical patients. Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine 26:1.
Crossref
Crossref
Anna Hall, Siobhan Crichton, Matt Varrier, Danielle E. Bear & Marlies Ostermann. (2018) suPAR as a marker of infection in acute kidney injury – a prospective observational study. BMC Nephrology 19:1.
Crossref
Crossref
Line J. H. RasmussenSteen LadelundThomas H. HauptGertrude E. EllekildeJesper Eugen-OlsenOve Andersen. (2018) Combining National Early Warning Score With Soluble Urokinase Plasminogen Activator Receptor (suPAR) Improves Risk Prediction in Acute Medical Patients: A Registry-Based Cohort Study*. Critical Care Medicine 46:12, pages 1961-1968.
Crossref
Crossref
Eun Young Kim, Naghmeh Hassanzadeh Khayyat & Stuart E. Dryer. (2018) Mechanisms underlying modulation of podocyte TRPC6 channels by suPAR: Role of NADPH oxidases and Src family tyrosine kinases. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1864:10, pages 3527-3536.
Crossref
Crossref
Juliette Tavenier, Thomas H. Haupt, Aino L. Andersen, Sussi F. Buhl, Anne Langkilde, Jens R. Andersen, Jens-Erik B. Jensen, Mette M. Pedersen, Janne Petersen & Ove Andersen. (2017) A high-protein diet during hospitalization is associated with an accelerated decrease in soluble urokinase plasminogen activator receptor levels in acutely ill elderly medical patients with SIRS. Nutrition Research 41, pages 56-64.
Crossref
Crossref